Daniel Staudenraus

发表

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.

H. Jäck, A. Nist, T. Stiewe, 2022, Cell death and differentiation.

Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults.

Bärbel Camara, M. Lohoff, V. Krähling, 2022, Nature microbiology.

Pro- and Antitumorigenic Capacity of Immunoproteasomes in Shaping the Tumor Microenvironment

Leon N. Schulte, H. Mollenkopf, A. Visekruna, 2021, Cancer Immunology Research.

IRF4 deficiency vulnerates B progeny for leukemogenesis via Jak3 mutations resembling Ph-like B-ALL in humans

H. Jäck, T. Stiewe, M. Buchholz, 2021 .

Pharmacological LXR activation with TO901317 modulates the expression profile of tumor-associated macrophages and the abundance of regulatory T cells in the tumor microenvironment

M. Huber, A. Valledor, C. Caelles, 2020 .

Differential durability of humoral and T cell immunity after two and three BNT162b2 vaccinations in adults aged >80 years

Bärbel Camara, M. Lohoff, V. Krähling, 2022, medRxiv.

Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment

E. Wagner, M. Huber, A. Valledor, 2020, Cancer Research.

Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation.

F. Zipp, A. Waisman, M. Looso, 2017, JCI insight.

IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity

H. Jäck, T. Stiewe, M. Buchholz, 2022, bioRxiv.

Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults

Bärbel Camara, M. Lohoff, V. Krähling, 2021, Nature Microbiology.

Dynamics of humoral and T-cell immunity after three BNT162b2 vaccinations in adults older than 80 years

Bärbel Camara, M. Lohoff, V. Krähling, 2022, The Lancet Infectious Diseases.

A hyperactive mutant of interferon‐regulatory factor 4

E. Hartmann, H. Raifer, A. Brüstle, 2018, European Journal of Immunology.

Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation.

F. Zipp, A. Waisman, M. Looso, 2017, JCI insight.

Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis

A. Chiocchetti, R. Zeiser, H. Bonig, 2023, Oncoimmunology.